Asylum Ventures
Brooklyn, NY · Invests in US · Website
Check size
$1M-$2M
Thesis
The best founders are artists — obsessive, compelled by novel ideas, and often initially misunderstood. Asylum backs these creative builders with capital and hands-on support when asked, without taking board seats or administrative control. Fund I is $55M deploying $1–2M checks at pre-seed and seed.
Likely not a fit for
No large fund dynamics, no board seats, no administrative control. Explicitly avoids the 'industrialization' of VC — no hundreds of investments per year, no assembly-line approach to dealmaking.
How they invest
- Lead or follow
- Usually leads
- Warm intro
- Not required
- Involvement
- Advisor
- Fund status
- Actively deploying
- Assets under mgmt
- $55M
- Decision process
- Partnership vote
Partners & team
4 contacts on file
Nicholas Chirls
Partner · Primary contact
Mackenzie Regent
Partner
Lola Wajskop
Partner
Jon Wu
Partner
Portfolio
Ark Robotics develops infrastructure for mass robotics, focusing on collaborative autonomy for military and industrial applications. Their systems enable secure, networked operation of robotic fleets, integrating real-time data for mission execution.
The Clearing Company is building a new kind of prediction market – onchain, permissionless and regulated. They aim to operate the first stablecoin-native clearinghouse purpose-built for prediction markets.
Hilbert is a scalable, data science-first growth infrastructure that provides B2C teams with predictive clarity into user behavior, revenue drivers, and the actions that drive sustainable growth. It utilizes AI/ML algorithms to turn fragmented data into actionable insights without the need for dashboards or complex coding.
Noso provides an AI-powered platform designed to enhance the efficiency of field technicians, particularly in the HVAC sector, by automating follow-ups on unsold estimates and integrating seamlessly with existing CRM and ERP systems.
An infinite playground for music creation where users can make music with friends and restore the freedom of musical expression.
Super Games creates games where fun rewards players with real money, aiming to make play feel bigger. The company focuses on casual gaming with genuine financial incentives.
Nucleus Genomics is a pioneering company in reproductive medicine, offering advanced genetic health testing and predictive models for embryo selection. Their platform, IVF+, utilizes cutting-edge genetic analysis to optimize the chances of having healthy babies, while their Origin models predict human longevity from embryonic DNA, setting new standards in genetic optimization.
Recent activity
- Jan 2025
Nucleus Genomics
Series A · Participated
- Feb 2025
Henlo
Seed · Participated
Asylum Ventures in the news
Business Insider
Meet the vibe coders who want to be the 'MrBeast' of apps
8 days ago
Business Wire
Pool Partners With First Internet Bank and Visa to Offer Multi-User Consumer Financial Accounts
9 months ago
citybiz
Alexis Ohanian-Backed Nucleus Closes $14 Million Series A to Push Genetic Testing
Feb 2025
TradingView
VC Roundup: Asylum Ventures launches $55M fund to back startup ‘artists,' not assets
Sep 2024
Fortune
Why Nanowear cofounder Venk Varadan isn’t chasing venture capital
Sep 2024
Newcomer | Substack
AI Coding Funding Frenzy...Down Rounds Are (Delightfully) Down...Miami Losing VC Luster
Sep 2024
The New York Times
Start-Up Investors Push Back Against Venture Capital’s Bigger-Is-Better Mantra (Published 2024)
Sep 2024
Similar firms
Invests across idea-to-IPO stages and uses formalized LP-to-portfolio collaboration with global influential families to open cross-border customers, partners, and markets for frontier-tech companies expanding productivity, health, and wealth.
Bi-continental, decentralized NY and Warsaw teams run a dedicated CEE-to-Japan commercialization channel. Partners relocated from Japan to Warsaw to connect CEE deep-tech with Japanese multinationals. Seed-stage deep-tech and AI-focused investment firm.
Operator Partners is a self-funded $40M-$70M venture fund run entirely on the partners own money without outside investors, led by founders with billion-dollar exits including Flatiron Health (acquired by Roche) and the first investor in fintech unicorn Plaid. They deliberately avoid leading rounds or taking board seats, instead writing $250K-$1M checks alongside lead investors while offering on-demand operator support to founders.
Research briefRead more
Add Asylum Ventures to your investor list
Sign up free to save investors, see partner contacts, and track your raise.
Sign up